These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25297648)

  • 41. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
    Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
    Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCs.
    Son JS; Park CY; Lee G; Park JY; Kim HJ; Kim G; Chi KY; Woo DH; Han C; Kim SK; Park HJ; Kim DW; Kim JH
    Biomaterials; 2022 Apr; 283():121429. PubMed ID: 35217482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A.
    Hemşinlioğlu C; Aslan ES; Taştan C; Çakırsoy D; Turan RD; Seyis U; Elek M; Sır Karakuş G; Günaydın ÖS; Abanuz S; Kançağı DD; Yurtsever B; Yalçın K; Kasap M; Ovalı E
    Turk J Haematol; 2023 May; 40(2):118-124. PubMed ID: 37022209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.
    Chen Y; Luo X; Schroeder JA; Chen J; Baumgartner CK; Hu J; Shi Q
    J Thromb Haemost; 2017 Oct; 15(10):1994-2004. PubMed ID: 28799202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-affinity von Willebrand factor binding does not affect the anatomical or hepatocellular distribution of factor VIII in rats.
    Øie CI; Roepstorff K; Behrens C; Bøggild Kristensen J; Karpf DM; Bolt G; Gudme CN; Kjalke M; Smedsrød B; Appa RS
    J Thromb Haemost; 2016 Sep; 14(9):1803-13. PubMed ID: 27378673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternative strategies for gene therapy of hemophilia.
    Montgomery RR; Shi Q
    Hematology Am Soc Hematol Educ Program; 2010; 2010():197-202. PubMed ID: 21239794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of factor VIII transgenes bioengineered for improved expression in gene therapy of hemophilia A.
    Dooriss KL; Denning G; Gangadharan B; Javazon EH; McCarty DA; Spencer HT; Doering CB
    Hum Gene Ther; 2009 May; 20(5):465-78. PubMed ID: 19222367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs.
    Sung JJ; Park CY; Leem JW; Cho MS; Kim DW
    Exp Mol Med; 2019 Apr; 51(4):1-9. PubMed ID: 30996250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring the Potential Feasibility of Intra-Articular Adeno-Associated Virus-Mediated Gene Therapy for Hemophilia Arthropathy.
    Zhang F; Yan X; Li M; Hua B; Xiao X; Monahan PE; Sun J
    Hum Gene Ther; 2020 Apr; 31(7-8):448-458. PubMed ID: 32079420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus-Mediated Gene Therapy in a Hemophilia A Mouse Model.
    Sun J; Yuan Z; Abajas YL; Szollosi DE; Hu G; Hua B; Xiao X; Li C
    Hum Gene Ther; 2018 Mar; 29(3):381-389. PubMed ID: 28922951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induced human pluripotent stem cells and advanced therapies: future perspectives for the treatment of haemophilia?
    Liras A
    Thromb Res; 2011 Jul; 128(1):8-13. PubMed ID: 21396685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.
    Merlin S; Cannizzo ES; Borroni E; Bruscaggin V; Schinco P; Tulalamba W; Chuah MK; Arruda VR; VandenDriessche T; Prat M; Valente G; Follenzi A
    Mol Ther; 2017 Aug; 25(8):1815-1830. PubMed ID: 28552407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero.
    Lipshutz GS; Sarkar R; Flebbe-Rehwaldt L; Kazazian H; Gaensler KM
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13324-9. PubMed ID: 10557319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-specific pluripotent stem cells: promises and challenges.
    Müller R; Lengerke C
    Nat Rev Endocrinol; 2009 Apr; 5(4):195-203. PubMed ID: 19352317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
    Doering CB
    Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
    Liu L; Mah C; Fletcher BS
    Mol Ther; 2006 May; 13(5):1006-15. PubMed ID: 16464640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII.
    Shahani T; Covens K; Lavend'homme R; Jazouli N; Sokal E; Peerlinck K; Jacquemin M
    J Thromb Haemost; 2014 Jan; 12(1):36-42. PubMed ID: 24118899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells.
    Shi Q; Kuether EL; Chen Y; Schroeder JA; Fahs SA; Montgomery RR
    Blood; 2014 Jan; 123(3):395-403. PubMed ID: 24269957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
    Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.